Banquil, Reymark L.

HRN: 29-48-01  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
CEFUROXIME 750MG (VIAL)
08/13/2026
08/20/2026
IV
750mg
Every 8hours
Fracture, Lacerated Wouns
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines